Иммуновоспалительный ответ у детей первого года жизни при операциях на открытом сердце в условиях искусственного кровообращения
Диссертация
Одной из актуальных проблем современной кардиоанестезиологии является анестезиологическое обеспечение и ведение послеоперационного периода после операций на открытом сердце у детей раннего возраста с врожденными пороками сердца (ВПС). Ее сложность обусловливается комплексом причин, кроющихся, с одной стороны, в многочисленных особенностях физиологии детей первого года жизни. С другой стороны… Читать ещё >
Список литературы
- Асланян A.A., Мунтян С. А. Изменение иммунологической реактивности у больных с желудочно-кишечными кровотечениями // Клиническая хирургия. 1999. № 8. С.10−13.
- Ассельдерова А.Ш. с соавт. Иммунопротекторный эффект церрулоплазмина в остром периоде у больных, перенесших критические состояния различного генеза. // Анестезиология и реаниматология. 1992. № 2. С.43−45.
- Богомолова Н. С. Абакумов Р.Н., Степаненко Р. Н. Иммунокорригирующее действие миелопида у больных после операции на сердце в условиях искусственного кровообращения // Иммунология. 1991. № 1. С.55−58.
- Брискин Б.С., Савченко 3.HV Хачатрян H.H., Евстидиева О. В. Иммунокоррегирующая терапия в профилактике осложнений в абдоминальной хирургии // Оказание специализированной помощи в неотложных состояниях. Челябинск. 1995. С. 41.
- Ганковская Л.В., Ковальчук Г. И. Окислительный метаболизм лейкоцитов новорожденных: особенности цитокин-зависимой регуляции // International jomal on immunorehabilitation. 2003. № 1. V.2. P. 128−132.
- Дударев И.В. Иммунологическая и гемодинамическая характеристика детей сврожденными пороками сердца синего и бледного типов // Иммунология. 2002. i1. Т.23. С.167−170.
- Ефремов В.А., Мизулин Ф. Ф., Начаров Ю. В. Общие принципы анализа гематологических изменений при патологических процессах // Учебно-методичекое пособие-Новосибирск.: Сибмедпздат. 2004. С. 15.
- Иванов Д.А. Клинико-лабораторные варианты течения сепсиса новорожденных: Автореф. дис.. д-ра мед. наук: 14.00.05 / ГОУВПО «Санкт-Петербургская госу-дарственная педиатрическая медицинская академия МЗ РФ». Санкт-Петербург, 2002. 32с.
- Исаков Ю.Ф., Белобородова Н. В. Сепсис у детей. М.: Издатель Мокеев. 2001. С.36−37.
- Кантюков С.А., Сергиенко В. И., Кривожихина JT.B., Осиков М. В. Влияние церрулоплазмина на количественный состав и функциональную активность лейкоцитов у интактных животных // Эфферентная терапия. 2003. Т.9. № 2. С.56−59.
- Караулов A.B. Клиническая иммунология и аллергология.-М.: Медицинское информационное агенство. 2002. С.38−49.
- Кетлинский С.А., Калинина Н. М. // Иммунолгия. 1995. № 3. С. З 0−44.
- Клебанов Г. И., Владимиров Ю. А. Клеточные механизмы прайминга и активации фагоцитов. // Успехи современной биологии 119(5). 1999. С.461−474.
- Кнышов Г. В., Воробьева A.M., Максименко В. Б., Моргунов О. И. Изменения иммунного статуса у пациентов с инфекционным эндокардитом при хирургическом лечении в условиях искусственного кровообращения / /Клин.Хирургия. 2001. № 12. С.5−7.
- Кожевников B.C., Киселев C.B., Коненкова Л.П, Крючкова ИВ. Метод оценки системной воспалительной реакции // Мед. Иммунология. 2001. Т.З. № 3. С.457−460.
- Котова Я.А., Мартынова Г. П., Савченко A.A. Особенности информативности параметров иммунного статуса и функциональной активности лейкоцитов крови у детей с острой кишечной инфекцией. Режим доступа: http://www.mednet.com 18.10.2004.
- Маянский А.Н., Невмятуллин A.JI. и соавт. Проблемы управления фагоцитами. //Журн. микробиол., эпидемиол., иммунобиол. 1995. № 3. С.21−26.
- Малашенкова И.К. Принципы иммунокорригирующей терапии вторичных иммунодефицитов, ассоциированных с хронической вирусно-бактериальной инфекцией. Режим доступа: http://www.dmied.ru/s.php/12 439.htm 08.11.2004.
- Назаренко Г. И., Кишкун A.A. Клиническая оценка результатов лабораторных исследований. М.: «Медицина»., 2002. С. 544.
- Насонов E. JL, Самсонов М. Ю. Новые аспекты патогенеза сердечной недостаточности: роль фактора некроза опухоли // Сердечная недостаточность. 2000. Том 1. N.4. С.75−79.
- Таболин В.А., Володин H.H. Актуальные вопросы перинатальной иммунологии // Int. J. on Immunorehabilitation. 1997. V.6. C. l 12−122.
- Петров P.B., Хаитов P.M., Пинегин Б. В. // Иммунология. 1997. № 4. С.4−7.
- Потапнев М.П. Апоптоз клеток иммунной системы и его регуляция цитокинами//Иммунология. 2002. Т.23(4). С. 237−242.
- Ройт А. Основы иммунологии: Пер. с англ. М: Мир, 1991. С. 10−15.
- Сухих Г. Т. Ванько Л.В. Иммунитет и генитальный герпес // М: НГМА. 1997. С.83−105.
- Хаитов Р.М., Петров Р. В. Метод определения субпопуляционнош состава клеток иммунной системы в цельной крови лимфоцитотоксическим тестом // Мед.Иммунология. 1992. № 6. С.51−62.
- Черешнев В.А., Гусев Е. Ю., Иммунология воспаления: роль цитокинов // Мед. Иммунология. 2001. Т.З. № 3. С.361−368.
- Черных Е.З., Леплина О. Ю., Тихонова М. А., Пальцев А. В., Останин А. А. Цитокиновый баланс в патогенезе системного воспалительного ответа: новая мишень иммунотерапевтических воздействий при лечении сепсиса // Мед. Иммунология. 2001. Т.З. №З.С.415−429.
- Шнепф Ф. Использование препаратов иммуноглобулина для внутривенного введения в неонатологии и акушерстве // Вопросы гинекологии, акушерства и перинатологии. 2002. Т.1. № 1. С. 12−22.
- Шабалов Н.П., Иванов Д. О. Неонатальный сепсис: клиника, диагностика и лечение // Российская Военно-Медицинская Академи, Санкт-Петербургская государственная педиатрическая медицинская академия (Академический медицинский журнал). 2001. Т.1.№ 3. С.81−88.
- Allen В., Ilbawi M. // Perfusion. 2001. V. 16. P.19−29.
- Allendorf J.D., Bessler M., Whelan R.L., Trokel M., Laird D.A., Terry M.B., Treat M.R. Postoperative immune function varies inversely with the degree of surgical trauma in murine model // Surg. Endosc. 1997. V. l 1. P.427−430.
- American College of Chest Physicians/Society of Critical Care Medicine
- Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. //Crit. Care Med. 1992. V.20. P.864−874.
- Andersen L.W., Baek L, Degn H. Presence of circulating endotoxins during cardiac operations // J. Thorac. Cardiovasc. Surg. 1987. V.(93). P. l 15−119.
- Aouifi A., Piriou V., Blanc P., Bouvier H., Bastien O., Chiari P., Rousson R., Evans R., Lehot J.J. Effect of cardiopulmonary bypass on serum procalcitonin and C-reactive protein concentrations // Br. J. Anaesth. 1999. Oct. V.83(4). P.602−607.
- Asimakopoulos G., Taylor K.M., Haskard D.O., Landis R.C. Inhibition of neutrophil L-selectin shedding: a potential anti-inflammatory effect of aprotinin // Perfusion. 2000. V.15 (6). P. 495−499.
- Asraf S., Bhattacharya K., Tian Y., Watterson K. Cytokine and S100B levels in paediatric patients undergoing corrective cardiac surgery with or without total circulatory arrest // Eur. J. Cardiothorac. Surg. 1999. V.16. P.32−37.
- Aziz K.A., Cawley J.C., Treweeke A.T., Zuzel M. Sequential potentiation and inhibition of PMN reactivity by maximally stimulated platelets // J. Leukoc. Biol. 1997. V.61. P.322−328.
- Barak M., Gruener N. Neopterin augmentation of tumor necrosis factor production // Immunol. Lett. 1991. P.30 101−30 106.
- Barrena M.J., Eizaguirre L., Aldazabal P., Cuadrado E., Bachiller P., Wang W., Tovar J.A. Lymphocyte subpopulation after extensive small bowel resection in the rat. // J. Pediatr. Surg. 1995. V.30. P.1447−1449.
- Baue A.E. Multiple, progressive or sequential systems failure a syndrome of the 70-s // Arch. Surg. 1975. V. 110. P. 779−785.
- Baue A.E. The role of the gut in the development of multiple organ dysfunction in cardiothoracic patients // Ann. Thorac. Surg. 1993. V.55. P.822−839.
- Bauman H., Gauldie J. // Immunology Today. 1994. V.15. № 2. P.74−80.
- Bazzoni F., Beutler B. Tumor necrosis factor ligand and receptor families // N. Engl. J. Med. 1996. V.334. P.1717−1725.
- Behr D., Hemvann A., Pouard P., Spizzi I., Leca F., Vouche P. Interleukin-6 and C-reactive protein during pediatric cardiopulmonary bypass // Clin. Chem. 1995. V.41. P.467169.
- Blackwell T.S., Blackwell T.R., Holden E.P., Christman B.W., Christman J.W. In vivo antioxidant treatment suppresses nuclear factor-kappa Bactivation and neutrophilic lung inflammation // J. Immunol. 1996. V.157. P.1603−1637.
- Boeken U., Feindt P. The influence of extracorporeal circulation and inflammatory responses as SIRS and sepsis on secretion of procalcitonin // J.Clin. Basic. Cardiol. 1999. P. 225−228.
- Bokesch P.M., Kapural M.B., Mossad E.B., Cavaglia M., Appachi E., Drummond-Webb J.J., Mee R.B. Do peritoneal catheters remove proinflammatory cytokines after cardiopulmonary bypass in neonatal // Ann. Thorac. Surg. 2000. V. 70 (2). P. 639−643.
- Boldt J., Osmer C., Schindler E. Circulating adhesion molecules in cardiac operations: influence of high-dose aprotinin // Ann. Thorac. Surg. 1995. V.59. P.100−105.
- Bone R.C., Charles J. Sepsis: a new hypothesis for pathogenesis of the disease process // Chest. 1997. V. 112. P. 235−243.
- Bot A., Antohi S. Immune response of neonates elicited by somatic transgene vaccination wiht naced DNA. // Frontiers in Bioscience. V.2. 1997. P. 173 188.
- Brix-Christensen V. The systemic inflammatory response after cardiac surgery whith cardiopulmonary bypass in children // Acta Anaesthesiol. Scand. 2001. V. 45. P. 671−679.
- Brix-Christensen V., Ravn H., Hjortdal V., T0nnesen E. Neutrophils accumulation after cardiopulmonary bypass in neonatal pigs (abstract) // Anesthesiology. 1999. V.91. P. 171.
- Brody H., Pickering N., Fink G. Altered lymphocyte subsets during cardiopulmonary bypass 11 Am. J. Clin. Pathol. 1987. V.87. P.626−628.
- Bukhari E.A., Krukenkamp I.B., Burns P.G. Does aprotinin increase the myocardial damage in the setting of ischemia and preconditioning? // Ann. Thorac. Surg. 1995. V.60. P.307−310.
- Burrows F.A., Steele R.W., Maimer D.J., van Devanter S.H., Westerman G.R. Influence of operations with cardiopulmonary bypass on polymorphonuclear leukocyte function in infants // J. Thorac. Cardiovasc. Surg. 1987. V.93. P.253−260.
- Butler J., Pillai R., Rocker G.M. Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor // J. Thorac. Cardiovasc. Surg. 1993. V.105. P. 25.
- Casali P., Schettino E.W. Structure and function of natural antibodies // Curr. Top. Microbiol. Immunol. V.210. 1996. P.167−179.
- Casey L.C. Role of cytokines in systemic capillary leak syndrome In: Aggarwal B.B., Puri R.K. Human cytokines: their role in disease and therapy //Cambridge.(MA): Blackwell.Science. 1995. P.601−607.
- Casey L.C., Balk R.A., Bone R: C. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome // Ann.Intem.Med. 1993. Oct.15. V.119(8). P.771−778.
- Chai P.J., Williamson J.A., Lodge A.J., Daggett C.W., Scarborough J.E., Meliones J.N. Effects of ischemia on pulmonary dysfunction after cardiopulmonary bypass // Ann. Thorac. Surg. 1999. V.67. P.731−735.
- Chello M., Mastroroberto P., Quirino A., Cuda G., Perticone F., Cirillo F., Covino E. Inhibition of neutrophil apoptosis after coronary bypass operation with cardiopulmonary bypass // Ann. Thorac. Surg. 2002. Jan.V.73(l). P.123−129.
- Chenoweth D.E., Cooper S.W., Hugli T.E. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins // N. Engl. J. Med. 1981. V.304. P.497−503.
- Chung C.S., Chaudry I.H., Ayala A. The apoptotic response of the lymphoid immune system to trauma, shock, and sepsis // Vincent J.L.- Year book of intensive care and amergency medicine. 2000. P.24−40.
- Collet B. Pathways to complement activation during cardio- pulmonary bypass //Br. Med. J. 1984. P. 1251−1254.
- De GreefK.E., Ysebaert D.K., Ghielli M-, Vercauteren S., Nouwen E.J., Eyskens E.J., De Broe M.E. Neutrophils and acute ischemia-reperfusion injury // J. Nephrol. 1998. V. 11. P. 110−122.
- De Palma L., Yu M., Mcintosh C. Changes in lymphocyte subpopulations as a result of cardiopulmonary bypass // J. Thorac. Cardiovasc. Surg. 1991. V.101. P.240−244.
- Donati A., Battisti D., Recchioni A., Peoletti P., Conti G, Caporelli S.
- Predictive value of interleukin 6 (IL-6), interleukin 8 (IL-8) and gastricintramucosal pH (pH-1) in major abdominal surgery // Intensive Care Med. 1998. V.24. P.329−335.
- Doughty L.A., Kaplan S.S., Carcillo J.A. Inflammatory cytokine and nitric oxide responses in pediatric sepsis and organ failure // Crit. Care. Med. 1996. V.24. P. l 137−1143.
- Dreyer W.J., Michael L.H. Neutrophil sequestration and pulmonary dysfunction in a canine model of open heart surgery with cardiopulmonary bypass: evidence for a CD18-dependent mechanism // Circulation. 1995. V.92. P.2276−2283.
- Dreyer W.J., Michael L.H., Millman EE,. Neutrophil activation and adhesion molecule expression in a canine model of open heart surgery with cardiopulmonary bypass// Cardiovasc. Res. 1995. V.29. P.775−781.
- Duval E., Kavelaars A., Veenhuizen L., van Vught A.J., van de Wal., Heijnen C.J. Pro- and anti-inflammatory cytokine patterns during and after cardiac surgery in young children // Eur. J. Pediatr. 1999. V.158. P.387−393.
- El Habbal, Carter H., Smith L.J., Eliott M., Strobel S., Neutrophili activation in paediatric extracorporeal circuits: effect of circulation and temperature variation // Cardiovasc. Res. 1995. V.25 .P. 102−107.
- Engle M. A, Zabriskie J.B., Senterfit L.B., Gay W.A., O’Loughlin J.E., Ehlers K.H. Viral illness and the pospericardiotomy syndrome: a prospective study in children // Circulation. 1980. V.62. P. l 151−1158.
- Engler R.L., Schmid-Schonbein G.W., Pavelec R.S. Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog // Am. J. Pathol. 1983. V.lll. P.98−111.
- Entman M.L., Michael L., Rossen R.D., Dreyer W.J., Anderson D.C., Taylor A.A., Smith C.W. Inflammation in the course of early myocardial ischaemia // FASEB J. 1991. V.5. P.2529−2537.
- Ertel W., Faist E., Dynamic of immunoglobulin synthesis after major trauma // Arch. Surg. 1989. V.124. № 12. P.1437−1442.
- Evora P.R., Pearson P.J., Schaff H.V. Impaired endotheliumdependent relaxation after coronary reperfusion injury: evidence for G-protein dysfunction//Ann. Thorac. Surg. 1994. V.57. P.1550−1556.
- Feinberg H., Rosenbaum D.S., Levitsky S., Silverman N.A., Kohler J, Le Breton G. Platelet deposition after, surgically induced myocardial ischemia // J. Thorac. Cardiovasc. Surg. 1982. V.84. P.815−822.
- Feldman A., Young J., Bourge R. Mechanism of increased mortality from vesmarinone in the severe heart failure. // J. Am. Coll. Cardiol. 1997. V.29. P.64.
- Ferrer-Lopez P., Renesto P., Schattner M., Bassot S., Laurent P., Chignard M. Activation of human platelets by C5a-stimulated neutrophils: a role for cathepsin // G. Am. J. Physiol. 1990. V.258. P. 1100−1107.
- Finn A., Naik S., Klein N. Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass // J. Thorac. Cardiovasc. Surg. 1993. V.105. P.234−241.
- Flesch M., Kilter H., Cremers B. Effects of endotoxin on human myocardial contractility involvment of nitric oxide and peroxynitrite // J. Am. Coll. Cardiol. 1999. V.33. P.1062−1070.
- Fosse E., Mollnes T.E., Ingvaldsen B. Complement activation during major operations with or without cardiopulmonary bypass // J. Thorac. Cardiovasc. Surg. 1987. V.93. P.860−866.
- Foster M.A., Pocklington T., Dawson A.A. In: // Metal. Ions in Biological Systems. 1979. V.10. P.129−166. .
- Frering B, Philip I, Dehoux M. Circulating cytokines in patients undergoing normothermic cardiopulmonary bypass // J. Thorac. Cardiovasc. Surg. 1994. V.108.P. 636.
- Gadaleta D, Fahey A. L, Verma M. Neutrophil leukotriene generation increases after cardiopulmonary bypass // J. Thorac. Cardiovasc. Surg. 1994. V.108. P.642−647.
- Gadient R. A, Patterson P. H. Leukemia inhibitory factor, interleukin 6, and other cytokines using the GP130 transducing receptor: roles in inflammation and injury// Stem. Cells. 1999. V.17. P. 127−137.
- Galley H. F, DiMattero M. A, Webster N.R. Immunomodulation by anaesthetic, sedative and analgesic agents: does it matter? // Intensive Care Med. 2000. V.26. P.267−274.
- Gessler P, Pfenninger J, et all Inflammatory response of neutrophil granulocytes and monocytes after cardiopulmonary bypass in pediatric cardiac surgery// Intensive Care Medicine. 2002. V.28(12). P. 1786−1791.
- Gil E. A, Imaizumi T. Bacterial lipopolysaccharide induces endothelial cells to synthesize a degranulating factor for neutrophils // FASEB J. 1998. V.12(9). P.673−684.
- Gil W. Inflammo-coagulatory response, extrinsic pathway thrombin generation and a new theory of activated clotting time interpretation. // Perfusion. 2001. Jan. 16(1). P. 27−35.
- Gilliland H. E, Armstrong M. A, McMurray T.J. The inflammatory response to pediatric cardiac surgery: Correlation of granulocyte adhesion molecule expression with postoperative oxygenation // Anesth. Analg. 1999. V.89. P. 1188−1191.
- Gillinov A.M., Bator J.M. Neutrophil adhesion molecule expression during cardiopulmonary bypass with bubble and membrane oxygenators // Ann. Thorac. Surg. 1993. V.56. P.847−853.
- Glavind-Kristensen M, Brix-Christensen V, Ravn H. B, T0nnesen E, Hjortdal V.E. Pulmonary endothelial dysfunction after cardiopulmonarybypass in neonatal pigs (abstract) // Acta. Anaesthesiol. Scand. 1999. V.43. A91.
- Greenough A. Neonatal infections // Curr. Opin. Pediatr. 1996. V.8(l). P.6−10.
- Gu Y.J., deVries A.J., Boonstra P.W., van Oeveren W. Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery// J. Thorac. Cardiovasc. Surg. 1996. V. l 12. P.494−500.
- Gu Y.J., van Oeveren W. Leukocyte activation with increased expression of CR3 receptors during cardiopulmonary bypass // Ann. Thorac. Surg. 1992. V.53. P.839−843.
- Gu Y.J., van Oeveren W., Akkerman C. Heparin-coated circuits reduce the inflammatory response to cardiopulmonary bypass // Ann. Thorac. Surg. 1993. V.55. P.917−922.
- Gurevitch J., Barak J., Hochhauser E. Aprotinin improves myocardial recovery after ischemia and reperfusion: effects of the drug on isolated rat hearts//J. Thorac. Cardiovasc. Surg. 1994. V.108. P.109−118.
- Habib F.M., Springall D.R., Davies G.J. Tumor necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy // Lancet. 1996. V.93. P.704 711.
- Hamberg M., Svensson J., Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides // Proc. Natl. Acad. Sci. USA. 1975. Aug.72(8). P.2994−2998.
- Hambsch J., Lenz D. Increased apoptosis of circulating leukocytes during cardiac surgery with cardiopulmonary bypass // Critical. Care. 2003. V.7(Suppl. 1). P. l 1
- Hammerschmidt D.E., Stroncek D.F., Bowers T.K. Complement activation and neutropenia occurring during cardiopulmonary bypass // J. Thorac. Cardiovasc. Surg. 1981. V.81. P.370−377.
- Haniuda M., Dresler C.M., Mizuta T., et al. Free radicalmediated vascular injury in lungs preserved at moderate hypothermia // Ann. Thorac. Surg-1995. V.60. P.1376−1381.
- Hansen P.R., Svendsen J.H., Hoyer S., Kharazmi A., Bendtzen K., Haunso S. Tumor necrosis factor-alpha increases myocardial microvascular transport in vivo//Am. J. Physiol. 1994. V.266. P.60−67.
- Hansen T.G., Tennesen E., Andersen J.B., Toft P., Bendtzen K. The perioperative cytokine response in infants and young children following major surgery// Eur. J. Anaesthesiol. 199&. V.15. P.56−60.
- Hashimoto K., Miyamoto H., Suzuki K. Evidence of organ damage after cardiopulmonary bypass: the role of elastase and vasoactive mediators // J. Thorac. Cardiovasc. Surg. 1992. V.104. P.666−673.
- Hill G.E., Alonso A., Spurzem J.R. Aprotinin and methylprednisolone equally blunt cardiopulmonary bypassinduced inflammation in humans // J. Thorac. Cardiovasc. Surg. 1995. V. l 10. P.1658−1662.
- Hoffman G., Schobersberg W., Frede S. Neopterin activates transcription factor nuclear factor-kB in vascular smoth muscular cells // FEBS- lett. 1987. V.15. P.181−184.
- Hoie E.B., McGuire T.R., Leuschen P.M., Zach T.L. Pentoxifylline inhibits tumor necrosis factor-alpha induced synthesis of complement component C3 in human endothelial cells // Biol. Pharm. Bull. 2004. V.27(10). P.1670−1673.
- Horgan M.J., Wright S.D. Antibody against leukocyte integrin (CD 18) prevents reperfiision-induced lung vascular injury // Am. J. Physiol. 1990. V. 259. P. 315−319.
- Hospers J.J., Rijcken B., Schouten J.P., Postma D.S., Weiss S.T. Eosinophilia and positive skin tests predict cardiovascular mortality in a general population sample followed for 30 years // Am. J. Epidemiol. 1999. V. 150. P. 482−491.
- Hovels-Gurich H.H., Schumacher K., Vazquez-Jimenez J.F., Quing M., Huffmeier U. Buding B., Messmer B.J., von Bernuth G., Seghaye M.C. Cytokine balance in infants undergoing cardiac operation // Ann. Thorac. Surg. 2002. V.73(2). P.601−609.
- Ide H., Kackiuchi T., Furata N. The effect of cardiopulmonary bypass on T cells and their subpopulations // Ann. Thorac. Surg. 1987. V.44. P.277−282.
- Jansen N.J., van Oeveren W. Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass // Ann. Thorac. Surg. 1992. V (54). P.744−748.
- Jansen P.G., te Velthuis H., Huybregts R. Reduced complement activation and improved postoperative performance after cardiopulmonary bypass withheparincoated circuits // J. Thorac. Cardiovasc. Surg. 1995. V.110. P.829−834.
- Jensen E., Andreasson S., Bengtsson A., Berggren H., Ekroth R., Lindholm L., Ouchterlony J. Influence of two different perfusion systems on inflammatory response in pediatric heart surgery // Ann. Thorac. Surg. 2003. Mar. V.75(3). P.919−925.
- Jensen E., Sandstrom K., Andreasson S., Nilsson K., Berggren H., Larsson L.E. Increased levels of S-100 protein after cardiac surgery with cardiopulmonary bypass and general surgery in children // Paediatr. Anaesth. 2000. V.10. P.297−302.
- Joris I., Majno G., Corey E.J., Lewis R.A. The mechanism of vascular leakage induced by leukotriene E4. Endothelial contraction. // Am. J. Pathol. 1987. V. 126(1). P. 19−24.
- Journois D., Israel-Biet D. Pouard P., Rolland B., Silvester W., Vouhe P., Safran D. High-volume, zero-balanced hemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children // Anesthesiology. 1996. V.85(5). P.965−976.
- Journois D., Pouard P., Greeley W.J. Hemofiltration during cardiopulmonary bypass in pediatric cardiac surgery: effects on hemostasis, cytokines, and complement components // Anesthesiology. 1994. V.81. P. 1181−1189.
- Kalman J., Levine B., Mayer L. Prognostic importance of circulating neopterin in geart failure: evidence for monocyte activation in patients with cardiac cachexia // Circulation. 1990. V.82 (Suppl. Ill): III-315 (abst.).
- Kawamura T., Wakusawa P., Inada K. Interleukin-10 and interleukin-1 receptor antagonists increase during cardiac surgery // Can. J. Anaesth. 1997. V.44. P.38−42.
- Kelly R.A., Balligand J.L., Smith T.W. Nitric oxide and cardiac function // Circ. Res. 1996. V.79. P.363−378.
- Kharazmi A., Andersen L.W. Endotoxemia and enhanced generation of oxygen radicals by neutrophils from patients undergoing cardiopulmonary bypass//J. Thorac. Cardiovasc. Surg. 1989. V. 98. P.381−385.
- Kimmel S.E., Sekeres M.A., Berlin J.A., Ellison N., DiSesa V.J., Strom B.L. Risk factors for clinically important adverse events after protamine administration following cardiopulmonary bypass // J. Am. Coll. Cardiol. 1998. V. 32. P. 1916−1922.
- Kirklin J.K., Westaby S. Blackstone E.H., Kirklin J.W., Chenoweth D.E., Pacifico A.D. Complement and the damaging effects of cardiopulmonary bypass// J. Thorac. Cardiovasc. Surg. 1983. V. 86. P.845−857.
- Korhonen K., Kiuru A., Svedstrom E., Kaapa P. Pentoxifylline Reduces Regional Inflammatory and Ventilatory Disturbances in Meconium-Exposed Piglet Lungs // Pediatr. Res. 2004. V.6. Epub ahead of print.
- Kotani N., Hashimoto H., Sessler D.I., Muraoka M., Wang J.S., O’Connor M.F. Cardiopulmonary bypass produces greater pulmonary than systemic proinflammatory cytokines // Anesth. Analg. 2000. V.90. P. 1039−1045.
- Kox W.J., Bone R.C., Krausch D., Interferon-gamma in the treatment of the compensatory anti-inflammatory response syndrome (CARS) -a new approach: proof of principle // Arch. Intern. Med. 1997. V.157. P.389−393.
- Krown K.A., Page M.T., Nguyen C. Tumor necrosis factor a-induced apoptosis in cardiac myocytes: involvment of the sphingolipid signaling cascade in cardiac cell death // J.Clin. Invest. 1996 V.98. P.2854−2865.
- Kucukaydin M., Kocaoglu C., Koksal F., Kontas O. Detection of intestinal bacterial translocation in subclinical ischemia-reperfusion using the polymerase chain reaction technique // J. Pediatr. Surg. 2000. Jan-35(l)-P.41−33.
- Landis R.C., Asimakopoulos G. Poullis M., Haskard D.O., Taylor K.M. The antithrombotic and antiinflammatory mechanisms of action of aprotinin // Ann. Thorac. Surg. 2001. V. 72 (6). P.2169−2175.
- Landis R.C., Haskard D.O., Taylor, K.M. New antiinflammatory and platelet-preserving effects of aprotinin // Ann. Thorac. Surg. 2001. V.72(5). P. 18 081 813.
- Langley S.M., Chai P.J., Jaggers J.J., Ungerleider R.M. Preoperative high dose methylprednisolone attenuates the cerebral response to deep hypothermic circulatory arrest // Eur. J. Cardiothorac. Surg. 2000. Mar. V.17(3). P.279−286.
- Laursen H., Waaben J., Gefke K., Husum В., Andersen L.I., Sorensen H.R. Brain histology, blood-brain barrier and brain water after normothermic and hypothermic cardiopulmonary bypass in pigs // Eur. J. Cardiothorac. Surg-1989. V.3. P.539−543.
- Le Deist F., Menasche' P., Kucharski C. Hypothermia during cardiopulmonary bypass delays but does not prevent neutrophil-endothelial cell adhesion: a clinical study // Circulation. 1995. V.92(suppl 2):II. P.354−358.
- Lefer A.M., Campbell B. Scalia R., Lefer D.J. Synergism between platelets and neutrophils provoking cardiac dysfunction after ischemia and reperfusion // Circulation. 1998. V. 98. P. 1322−1328.
- Lefer A.M., Lefer D.J. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion // Cardiovasc. Res. 1996. V.32. P.743−751.
- Lefer D.J., Shandelya S.M. Serrano C.V., Becker L.C., Kuppusamy P., Zweier J.L. Cardioprotective actions of a monoclonal antibody against CD-18 in myocardial ischemic-reperfusion injury // Circulation. 1993. V.88. P. 17 791 787.
- Leteurtre S., Martinot A., Duhamel A., Gauvin F., Grandbastien B., Nam T.V., Proulx F., Lacroix J., Leclerc F. Development of a pediatric multiple organ dysfunction score: use of two strategies. // Med. Decis. Making. 1999. Oct-Dec-19(4). P.399110.
- Lindal S., Vaage J., Olsen R., Straume B.K., Jergensen L., Sorlie D. Endothelial injury and trapping of blood cells in human myocardium following coronary bypass surgery // Scand. Cardiovasc. J. 1999. V.33. P.143−150.
- Lindberg L., Olsson A-K, Anderson K., Jogi P. Serum S-100 protein levels after pediatric cardiac operations: a possible new marker for postperfusion cerebral injury// J. Thorac. Cardiovasc. Surg. 1998. V. l 16. P.281−285.
- Lucchesi B.R. Modulation of leukocyte-mediated myocardial reperfusion injury // Annu. Rev. Physiol. 1990. V.5. P.561−576.
- MacLellan W.R., Schneider M.D. Death by design. Programmed cell death in cardiovaccular biology and disease // Circ. Res. 1997. V.81-P.137−144.
- Mallat A., Tedgui A., Fontaliran F. Evidence of apoptosis in arrythmogeiiic right ventricular dysplasia II N.Engl. J. Med. 1996. V.335. P. 1190−1196.
- Markewitz A., Lante W., Franke A., Marohl K., Kuhlmann W.D., Weinhold C. Alterations of cell-mediated immunity following cardiac operations: clinical implications and open questions // Shock. 2001. V.16.Suppl.l. P. 10
- McBride W.T., Armstrong M.A., Gilliland H., McMurray T.J. The balance of pro and anti-inflammatory cytokines in plasma and bronchoalveolar lavage (BAL) at paediatric cardiac surgery// Cytokine. 1996. V.8. P.724−729.
- McBride W.T., McBride S.J. The balance of pro- and anti-inflammatory cytokines in cardiac surgery // Curr. Opin. Anesth. 1998. V. l l.P. 15−22.
- McConnell J.R., Fleming W.H., Chu W-K, Hahn F., Sarafian L.B., Hofschire P.J. Magnetic resonance imaging 6f the brain in infants and children before and after cardiac surgery // AJDS. 1990. V.144. P.374−379.
- McEver R.P. Leukocyte interactions: mediated by selectins // Thromb. Haemost. 1991. V.66. P.80−87.
- McGowan F.X., Ikegami M., del Nido P.J., Motoyama E.K., Kurland G., Davis P.J. Cardiopulmonary bypass significantly reduces surfactant activity in children // J. Thorac. Cardiovasc. Surg. 1993. V.106. P.968−977.
- Mehta J.L. Endothelium, coronary vasodilation, and organic nitrates // Am. Heart. J. 1995. V.129. P.382−391.
- Menasche' P., Peynet J., Haeffner-Cavaillon N. Influence of temperature on neutrophil trafficking during clinical cardiopulmonary bypass // Circulation. 1995. V.92(suppl 2):II. P.334−340. >
- Menasche' P., Peynet J., Larivie" re J. Does normothermia during cardiopulmonary bypass increase neutrophil-endothelium interactions? // Circulation. 1994. V.90(pt 2):II. P.275−279.
- Millar A.B., Armstrong L., van der Linden J. Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass // Ann. Thorac. Surg. 1993. V.56. P.1499−1502.
- Naldini A., Borrelli E., Cesari S., Giomarelli P., Toscano M. In vitro cytokine production and T-cell proliferation in patients undergoing cardiopulmonary by-pass // Cytokine. 1995. Feb-V.7(2). P.165−170.
- Neumann F.J., Marx N., Gawaz M., Brand K., Ott I., Rokitta C., Sticherling C., Meinl C., May A., Schomig A. Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets // Circulation. 1997. V.95. P.2387−2394.
- Nguyen D., Mulder D., Shennib H. Effect of cardiopulmonary bypass on circulating lymphocyte function // Ann. Thorac. Surg. 1992. V.53. P.611−616.
- Olivencia-Yurvati A.H., Ferrara C.A., Tierney N., Wallace N., Mallet R.T. Strategic leukocyte depletion reduces pulmonary microvascular pressure and improves pulmonary status post-cardiopulmonary bypass // Perfusion. 2003. V.18. Suppl.l. P.23−31.
- Ozawa T., Yoshihara K., Koyama N., Watanabe Y., Shiono N., Takanashi Y. Clinical efficacy of heparin-bonded bypass circuits related to cytokine responses in children//Ann. Thorac. Surg. 2000. V.69. P.584−590.
- Pearl JM, Nelson DP, Schwartz S.M., Wagner C.J., Bauer S.M., Setser E.A., Duffy J.Y. Glucocorticoids reduce ischemia-reperfusion-induced myocardial apoptosis in immature hearts // Ann. Thorac. Surg. 2002. V.74. P.830−836.
- Perttila J., Salo M., Pirttikangas C.O., Jalonen J., Vainio O. Effects of cardiopulmonary bypass on lymphocytes and their subset counts with or without use of autotransfusion devices // J. Cardiothorac. Vase. Anesth. 1994. V.8(5). P.532−535.
- Picca S., Principato F. Risks of acute renal failure after cardiopulmonary bypass surgery in children: a retrospective 10-year case-control study // Nephrology Dialysis Transplantation. 1995. V.10. P.5630−5636.
- Pinsky D.J., Cai B., Yang X. The lethal effects of cytokine-induced nitric oxide on cardiac myocytes are blocked by nitric oxide synthase antahonism or transforming growth factor// J.Clin. Invest. 1995. V.95. P.677−685.
- Pinsky D.J., Yang Y., Aji W. Nitric oxide induces apoptosis of adult cardiac myocytes // Circulation. 1995. V.92 (Suppl. 1). 1−562 (abst.).
- Plotz F.B., van Oeveren W., Bartlett R.H., Wildevuur C.R. Blood activation during neonatal extracorporeal life support // J. Thorac. Cardiovasc. Surg. 1993. V.105. P.823−832.
- Plotz F.B., van Oeveren W., Hultquist K.A. A heparincoated circuit reduces complement activation and the release of leukocyte inflammatory mediators during extracorporeal circulation in a rabbit // Artif. Organs. 1992. V.16. P.366−370.
- Pollock R., Ames R., Rubio P. Protracted severe immune deregulation induced by cardiopulmonary bypass: a predisposing etiologic factor in blood transfusion-related AIDS? // J. Clin. Lab. Immunol. 1987. V.22. P. 1−5.
- Prendergast T.W., Furukawa S., Beyer A.J. Defining the role of aprotinin in heart transplantation // Ann. Thorac. Surg. 1996. V.62. P.670−674.
- Pua H.L., Bissonnette B. Cerebral physiology in paediatric cardiopulmonary bypass // Canadian Journal of Anesthesia. 1998. V. 45. P. 960−978.
- Pyles L.A., Fortney J.E., Kudlak J.J. Plasma antioxidant depletion after cardiopulmonary bypass in operations for congenital heart disease // J. Thorac. Cardiovasc. Surg. 1995. V.110. P.165−171.
- Riddington D.W., Venkatesh B. Intestinal permeability, gastric intramucosal pH, and systemic endotoxemia in patients undergoing cardiopulmonary bypass//JAMA. 1996. V.275. P. 1007−1012.
- Rinder C.S., Bonan J.L. Cardiopulmonary bypass induces leukocyte adhesion //Blood. 1992. V.79. P.1201−1205.
- Rocke D.A., Gaffin S.L. Endotoxemia a associated with cardiopulmonary bypass//J. Thorac. Cardiovasc. Surg. 1987. V.93. P.832−837.
- Rodeberg D.A., Chaet M.S., Bass R.C. Nitric oxide: an overview // Am. J. Surg. 1995. V.170. P.292−303.
- Roth J., Golub S., Cuckingnan R. Cell-mediated immunity is depressed following cardiopulmonary bypass // Ann. Thorac. Surg. 1981. V.31. P.350−356.
- Ruvolo G., Greco E., Speziale G. Nitric oxide formation during cardiopulmonary bypass // Ann. Thorac. Surg. 1994. V.57. P. 1055−1056.
- Ryhaenen P., Huttunen K., Llonen J. Natural killer cell activity after open heart surgery//Acta. Anaesth. Scand. 1984. V.28. P.490−492.
- Sahlman A., Ahonen J., Salo J.A., Ramo O.J. No impact of a leucocyte depleting arterial line filter on patient recovery after cardiopulmonary bypass // Acta. Anaesthesiol. Scand. 2001. V.45(5). P.558−563.
- Sakai Y., Watanabe T. Inflammatory response during cardiopulmonary bypass: neutrophil apoptosis // Kyobu. Geka. 1998. Nov-V.51(12). P. 10 241 026.
- Satoh M., Nakamura M., Tamura G. Inducible nitric oxide synthase and tumor necrosis factor-a in myocardium in human dilated cardiomyopathy // J. Am. Coll. Cardiol. 1997. V.29. V.716−724.
- Schelonka R.L., Infonte A.G. Neonatal. Immunogy // Semin. Perinatol. 1998. V.22. P.2−14.
- Schibler K.R., Liechty K.W., White W.L., Rothstein G., Christensen R.D. Defective production of interleukin-6 by monocytes: a possible mechanism underlying several host defense deficiencies of neonates // Pediatric. Research. V.31. P. 18−21.
- Schobersberg W., Hoffman G., Hobisch-Hagen P. Neopterin and 7?8-dihydroneopterin induce apoptosis in the rat alveolar epithelial cell line // FEBS Lett. 1996. V.397. P.263−268.
- Schulze-Neick I., Penny D.J., Rigby M.L., Morgan C., Kelleher A., Collins P. L-Arginine and substance P reverse the pulmonary endothelial dysfunction caused by congenital heart surgery// Circulation.-1999.-V.100.-P.749−755.
- Scott M.E., Kubin M., Kohl S., High level interleukin-12 production, but diminished interferon-gamma production, by cord blood mononuclear cells // Pediatr. Res. 1997. V.41. P.547−553.
- Seccombe J.F., Pearson P.J., Schaff H.V. Oxygen radicalmediated vascular injury selectively inhibits receptor-dependent release of nitric oxide from canine coronaiy arteries // J. Thorac. Cardiovasc. Surg. 1994. V.107. P.505−509.
- Seghaye M.C., Duchateau J., Bruniaux J., Demontoux S., Bosson C., Serraf A. Interleukin-10 release related to cardiopulmonary bypass in infants undergoing cardiac operations // J.Thorac. Cardiovasc. Surg. 1996. V.lll. P.545−553.
- Seghaye M.C., Duchateau J., Grabitz R.G. Influence of low-dose aprotinin on the inflammatory reaction due to cardiopulmonary bypass in children // Ann. Thorac. Surg. 1996a. V.61. P.1205−1211.
- Semb A.G., Forsdahl K., Vaage J. Granulocyte and eicosanoid gradients across the coronary circulation during myocardial reperfusion in cardiac surgery// Eur. J. Cardiothorac. Surg. 1990. V.4. P.543−548.
- Sennikov S.V., Krysov S.V., Injelevskaya T.V., Silkov A.N., Grishina L.V., Kozlov V.A. Quantitative analysis of human immunoregulatory cytokines by electrochemiluminescence method //J. Immun. Methods. 2003. V.275. № 1−2. P.81 88.
- Sharov V.G., Sabbah H.N., Shimoyama H. Evidence of cardiomyocyte apoptosis in myocardium in dogs with chronic heart failure // Am. J. Pathol. 1996. V.148. P.1506−1512.
- Shindo T., Ikeda U., Ohkawa F. Nitric oxide synthesis in cardiac myocytes and fibroblasts by inflammatory cytokines // Cardiovasc. Res.-1995.-V.29.-P.813−819.
- Simmons W.W., Ungureanu-Longrois D., Smith G.K. Glucocorticoids regulate inducible nitric oxide synthase (NOS2) by inhibiting tetrahydrobiopterin synthesis and L-arginine transport // J. Biol. Chem. 1996. V.271. P.23 928−23 937.
- Sinclair D.G., Haslam P.L. The effect of cardiopulmonary bypass on intestinal and pulmonary endothelial permeability // Chest. 1995. V.108. P.718−724.
- Sisto T., Paajanen H, Metsa-Ketela T. Pretreatment with antioxidants and allopurinol diminishes cardiac onset events in coronary artery bypass grafting // Ann. Thorac. Surg. 1995. V.59. P.1519−1523.
- Song W, Jean-Louis L. Inflammatory Response to Cardiopulmonary Bypass: Mechanisms Involved and Possible Therapeutic Strategies // Chest. 1997. V.112. P.676−692.
- Souza A. L, Poggetti R. S, Fontes B, Birolini D. Gut ischemia/reperfusion activates lung macrophages for tumor necrosis factor and hydrogen peroxide production // J. Trauma. 2000. Aug-49(2). P.232−236.
- Spiegelhalter D. J. Mortality and volume of cases in paediatric cardiac surgery: retrospective study based on routinely collected data // B.M.J. 2002. V. 2. 324 (7332). P.261.
- Steinberg B. M, Grossi E. A, Schwarz D.S. Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass // Ann. Thorac. Surg. 1995. V.60. P.525−529.
- Sugita T, Watasida S, Katsuyama K., Nakajima Y, Yamamoto R, Mori A. Interleukin-10 concentration in cildren undergoing CPB // J. Thorac. Cardiovasc. Surg. 1996. V.112. P. l 127−1128.
- Suzuki M., Asako H., Kubes P., Jennings S., Grisham M.B., Granger D.N. Neutrophil-derived oxidants promote leukocyte adherence in postcapillaryvenules // Microvasc. Res. 1991. V.42. P. 125−138./
- Tabardel Y., Duchateau J., Schmartz D., Marecaux G., Shahla M., Barvais L., Leclerc J.L., Vincent J.L. Corticosteroids increase blood interleukin-10 levels during cardiopulmonary bypass in men // Surgery. 1996. Jan.V.l 19(1). P.76−80.
- Tajima K., Yamamoto F., Kawazoe K., Hirata T., Kumon K., Tanaka K., Fujita T. Effect of immune response during cardiopulmonary bypass on postoperative infections // Nippon Kyobu Geka Gakkai Zasshi. 1989. V.37(4). P.671−675.
- Tanita T., Song C., Kubo H., Hoshikawa Y., Ueda S., Fujimura S. Superoxide possibly produced in endothelial cells mediates the neutrophil-induced lung injury // Ann. Thorac. Surg. 2000. V.69(2). P.402107.
- Tao W., Zwischenberger J.B. Gut mucosal ischemia during normothermic cardiopulmonary bypass results from blood flow redistribution and increased oxygen demand // J. Thorac. Cardiovasc. Surg. 1995. V. l 10. P.819−828.
- Tarnok A., Hambsch J., Schneider P. Cardiopulmonary bypass-induced increase of serum interleukin-10 levels in children // J. Thorac. Cardiovasc. Surg. 1998. V. l 15. P.475−477.
- Tarnok A., Schneider P. Pediatric cardiac surgery with cardiopulmonary bypass: pathways contributing to 'transient systemic immune suppression // Shock. 2001. V.16(l). P.24−32.
- Tassani P., Kunkel R. Effect of Cl-esterase-inhibitor on capillary leak and inflammatory response syndrome during arterial switch operations in neonates // J.Cardiothorac. Vase. Anesth. 2001. V. 15 (4) P. 183−201.
- Tofukuji M., Stahl G.L., Agah A., Metais C., Simons M., Sellke F.W. Anti-C5a monoclonal antibody reduces cardiopulmonaiy bypass and cardioplegia-induced coronary endothelial dysfunction // J. Thorac. Cardiovasc. Surg. 1998. V. l 16. P.1060−1068.
- Topham M.K., Carveth H.J., Mclntyre T.M., Prescott S.M., Zimmemian G.A. ' Human endothelial cells regulate polymorphonuclear leukocyte degranulation // FASEB J. 1998. V. l2(9). P.733−746.
- Torre-Amione G., Kapadia S., Lee J. Overexpression and functional significance of tumor necrosis factor receptors in human myocardium // Circulation. 1995. V.92. P. 1487−1493.
- Torre-Amione G., Stetson S.S., Farmer J.A. Clinical implications of tumor necrosis factor a antagonist in patients with congestive heart failure // Ann. Rheum. Dis. 1999. V.58. Suppl. 1. P.1103−1106.
- Treacher D.F., Sabbato M., Brown K. A, Gant V. The effects of leucodepletion in patients who develop the systemic inflammatory response syndrome following cardiopulmonary bypass // Perfusion. 2001. V.16. Suppl. P.67−73.
- Trotter A., Muck K., Grill H., Schirmer U., Hannekum A., Lang D. Gender-related plasma levels of progesterone, interleukin-8 and interleukin-10 during and after cardiopulmonaiy bypass in infants and children // Crit. Care. 2001. V.5(6). P.343−348.
- Tsao P. S., Aoki N. Lefer D.J., Johnson G., Lefer A.M. Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat // Circulation. 1990. V.82. P.1402−1412.
- Tsujino M., Hirata Y., Imai T. Induction of nitric oxide synthase gene by interleukin-lb in cultured rat cardiocytes // Circulation. 1994. V.90. P.375−383.
- UeyamaM., MaruyamaI., OsaneM., Sawada J. // J.lab. and Clin. Med-1992. V. l2. N5. P.693−698.
- Utley J.R. Pathophysiology of cardiopulmonary bypass: current issues // J. Card. Surg. 1990. V.5. P. 177−189.
- Vale M.L., Benevides V.M., Sach$ D., Brito G.A., da Rocha F.A., Poole S., Ferreira S.H., Cunha F.Q., Ribeiro R.A. Antihyperalgesic effect of pentoxifylline on experimental inflammatory pain // Br. J. Pharmacol. 2004. V. 1 Epub ahead of print.
- Van Dissel J.T., van Langevelde P., Westendorp R.G., Kwappenberg K., Frolich M. Anti-inflammatory cytokine profile and mortality in febrile patients // Lancet. 1998. V.351. P.950−953.
- Van Velzen-Blad Ii., Dijkstra Y., Schurink G. Cardiopulmonary bypass and host defense functions in human beings: serum levels and the role of immunoglobulins and complement in phagocytosis // Ann. Thorac. Surg. 1985. V.39. P.207−213.
- Varan B., Tokel S., Mercan A., Donmez S., Aslamaci Sistemic inflammatory response related to CPB and its modification by methyl prednisolone: high dose versus low dose // Pediatr. Cardiol. 2002. V.23. P.437−441.
- Velthuis H., Jansen P. Myocardial performance in elderly patients after cardiopulmonary bypass is suppressed by tumor necrosis factor. // J. Thorac. Cardiovasc. Surg. 1995. V.110. P. 1663−1669.
- Vigano A., Esposito L.M., Arienti D., Zagliani A., Massironi E., Principi N. Differential development of tipe 1 and tipe 2 cytokines and beta-chemokines in the ontogeny of healthy newborns // Biol. Neonate. 1999. V.75. P. 1−8.
- Wachtfogel Y.T., Kucich U., Hack C.E. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion // J. Thorac. Cardiovasc. Surg. 1993. V.106. P. 1−10.
- Wan S., LeClerc J.L., Vincent J.L. Cytokine responses to cardiopulmonary bypass: lessons learned from cardiac transplantation // Ann. Thorac. Surg. 1997. V.63. P.269−276.
- Wang M., Cliiu I., Hsu C., Wang C., Lin P., Chang C., Huang C., Chu S. Efficacy of ultrafiltration in removing inflammatory mediators during pediatric cardiac operations // Ann. Thorac. Surg. 1996. V.61. P.651−656.
- Wang W., Huand H.M., Zhu D., «Chen H., Su Z.K., Ding W.X. Modified ultrafiltration in pediatric cardiopulmonary bypass // Perfusion. 1998. V.13. P.304−310.
- Weerwind P.W., Maessen J.G., van Tits L.J.H. Influence of Duraflo II heparin-treated extracorporeal circuits on the systemic inflammatory response in patients having coronary bypass // J. Thorac. Cardiovasc. Surg. 1995. V.110. P.1633−1641.
- Wessel D.L., Adatia I., Giglia T.M., Thompson J.E., Kulik T.J. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass // Circulation. 1993. V.88. P.2128−2138.
- Whicher J.T. Marker proteins in inflammation // N-Y.-1984. V.2. P. 88 98.
- Whitaker D.C., Stygall J.A., Newman S.P., Harrison M.J. The use of leucocyte-depleting and conventional arterial line filters in cardiac surgery: a systematic review of clinical studies // Perfusion. 2001. V.16(6). P.433446.
- Whitehouse M.W. Anti-TNF-alpha therapy for chronic inflammation: reconsidering pentoxifylline as an alternative to therapeutic protein drugs // Inflammopharmacology. 2004. V.12(3). P.223−227.
- Xu D.Z., Lu Q., Kubicka R., Deitch E.A. The effect of hypoxia/reoxygenation on the cellular function of intestinal epithelial cells. // J. Trauma. 1999. Feb-46(2). P.280−285.
- Zehr K.J., Poston R.S., Lee P.C., Uthoff K., Kumar P., Cho P.W. Platelet activating factor inhibition reduces lung injury after cardiopulmonary bypass // Ann. Thorac. Surg. 1995. V.59. P.328−335.
- Zhang M., Tracey K.J. Tumor necrosis factor. In: Thompson A.W., er. // The cytokine handbook, 3rd ed. New York. Academic press. 1998. P.515−548.
- Zhong W., Qin Zen, Julie Tebo, Schlottmann K., Coggeshall M., Mortensen R.F. Effect of Human C-Reactive Protein on Chemokine and Chemotactic Factor-Induced Neutrophil Chemotaxis and Signaling // The Journal of Immunology. 1998. V.161. P.2533−2540.